Nano X Imaging Ltd
$ 2.47
3.78%
14 Apr - close price
- Market Cap 165,625,000 USD
- Current Price $ 2.47
- High / Low $ 2.50 / 2.43
- Stock P/E N/A
- Book Value 2.40
- EPS -0.88
- Next Earning Report 2026-04-20
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.20 %
- ROE -0.35 %
- 52 Week High 5.86
- 52 Week Low 2.11
About
Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is headquartered in Neve Ilan, Israel.
Analyst Target Price
$7.40
Quarterly Earnings
| Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-06 | 2025-11-20 | 2025-08-12 | 2025-05-26 | 2025-03-31 | 2024-11-26 | 2024-08-20 | 2024-05-28 | 2024-03-07 | 2023-11-28 | 2023-08-17 | 2023-05-22 |
| Reported EPS | 0 | -0.15 | -0.23 | -0.2338 | -0.17 | -0.15 | -0.23 | -0.21 | -0.18 | -0.37 | -0.31 | -0.21 |
| Estimated EPS | -0.1925 | -0.21 | -0.19 | -0.15 | -0.15 | -0.22 | -0.22 | -0.26 | -0.3 | -0.3 | -0.26 | -0.34 |
| Surprise | 0.1925 | 0.06 | -0.04 | -0.0838 | -0.02 | 0.07 | -0.01 | 0.05 | 0.12 | -0.07 | -0.05 | 0.13 |
| Surprise Percentage | 100% | 28.5714% | -21.0526% | -55.8667% | -13.3333% | 31.8182% | -4.5455% | 19.2308% | 40% | -23.3333% | -19.2308% | 38.2353% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-20 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NNOX
2026-04-14 11:40:24
Nanox Imaging Ltd. has partnered with Meir Medical Center to conduct a clinical study on the Nanox.ARC system for orthopedic injury diagnosis in emergency departments. The collaboration aims to validate the diagnostic value of Nanox.ARC, a multisource digital tomosynthesis system, by comparing it with existing methods and demonstrating its ability to provide more detailed 3D anatomical information with lower radiation. This study is expected to enhance efficiency and decision-making for orthopedic injuries, supporting broader adoption of Nanox's technology for accessible 3D imaging.
2026-04-14 11:40:24
Nanox (Nasdaq: NNOX) announced a clinical collaboration with Meir Medical Center to evaluate its Nanox.ARC multisource digital tomosynthesis system for emergency orthopedic imaging. This IRB-approved study will compare the Nanox.ARC to conventional radiography and CT for fracture detection, focusing on diagnostic confidence, speed, and reduced radiation dose. The collaboration aims to build clinical evidence for the broader adoption of Nanox.ARC as a more efficient and lower-radiation diagnostic pathway for orthopedic injuries.
2026-04-14 11:40:24
Nanox (NASDAQ: NNOX) has announced a clinical collaboration with Meir Medical Center in Israel to deploy its Nanox.ARC system for orthopedic injuries in emergency departments. The study aims to validate the diagnostic value of Nanox.ARC, comparing it to existing diagnostic workflows, and demonstrate its ability to provide detailed anatomical information with lower radiation doses than traditional CT scans. This partnership seeks to enhance clinical decision-making, improve efficiency, and support the broader adoption of Nanox's advanced imaging technology.
2026-04-13 18:40:24
Nano X Imaging Ltd. (NNOX) has signed a distribution agreement with Digital X-Ray Imaging Inc. to deploy its FDA-cleared Nanox.ARC digital tomosynthesis system across Arkansas. This marks Nanox's fourth U.S. distribution collaboration in 2026 and aims to expand access to affordable 3D imaging in various clinical settings. Digital X-Ray Imaging will market, install, and support the Nanox.ARC through its established network and expertise in the region.
2026-04-13 18:39:35
D. Boral Capital has reiterated a "Buy" rating for Nano-X Imaging (NASDAQ:NNOX) and set a price target of $5.00, suggesting a potential upside of 109.6% from its previous close. The company's stock rose 5.1% to $2.39, with institutional ownership at 21.49% and significant increases in holdings by several investment firms. Nano-X Imaging is a medical technology company focused on developing and commercializing a digital X-ray imaging platform, the Nanox.ARC, to improve diagnostic imaging accessibility and affordability.
2026-04-13 12:38:38
Nano X Imaging Ltd. (NNOX) has signed a distribution agreement with Digital X-Ray Imaging Inc. (DXI) to deploy its FDA-cleared Nanox.ARC digital tomosynthesis system in Arkansas. This marks Nanox's fourth U.S. distribution collaboration in 2026, aiming to expand the availability of cost-effective 3D imaging solutions to healthcare facilities. DXI will market, install, and support the Nanox.ARC through its established network, leveraging decades of experience in the region.
